Gustavo Adolfo Gámez, Colombia

Basic and Applied Microbiology (MICROBA) Research Group School of Microbiology, University of Antioquia, UdeA

Author Of 6 Presentations

POST-VACCINATION EPIDEMIOLOGY OF PNEUMOCOCCAL CARRIAGE AMONG CHILDREN YOUNGER THAN FIVE YEARS OF AGE IN CAPE COAST, GHANA (ID 685)

GENOMIC CHARACTERIZATION OF STREPTOCOCCUS PNEUMONIAE SEROTYPE 19A ISOLATES CAUSING INVASIVE PNEUMOCOCCAL DISEASES AMONG CHILDREN AND ELDERLY FROM BOGOTÁ, COLOMBIA (ID 432)

CHARACTERIZATION OF STREPTOCOCCUS PNEUMONIAE SEROTYPE 19A CAUSING INVASIVE PNEUMOCOCCAL DISEASE FROM BOGOTÁ, COLOMBIA (ID 997)

Abstract

Background

Invasive Pneumococcal Disease (IPDs) is a leading cause of morbidity and mortality. In Colombia, the 7-valent pneumococcal conjugate vaccine was introduced in 2006 and replaced in 2011 by 10-valent. However, the number of S.pneumoniae serotype-19A causing IPDs in Bogotá has considerably increased in the last years. Thus, we characterized all S.pneumoniae serotype-19A isolates received from the Public Health Laboratory Network of Bogotá (PHLNB) in 2017, after Pneumococcal Conjugate Vaccine implementation.

Methods

This study was conducted with all S.pneumoniae serotype-19A isolates received in 2017 from PHLNB. Standard laboratory methods were performed for pneumococcal culture. Identification and antimicrobial susceptibility/resistance were done by automated method (VITEK-BioMérieux). Serotyping results (Quellung Reaction) were received by feedback of the Colombian National Institute of Health. Statistical analysis: Excel/SPSS.

Results

In 2017, 227 S.pneumoniae IPD-isolates were received from PHLNB. The most prevalent serotypes were 19A/3/23A/9N/6C/14/35B. Serotype-19A accounted for 20.3% (46/227) of IPD-isolates. Twenty-two (47.8%) children <5 years were affected by this serotype in 2017 with Pneumonia (39.1%) and Sepsis (34.9%). All 46 serotype-19A were susceptible to vancomycin and chloramphenicol, while reduced susceptibility and/or resistance was observed for erythromycin (100%), penicillin (65.2%) and Trimetoprim-Sulfametoxazol (58.7%).

Conclusions

These results evidence the predominant emergency of S.pneumoniae multidrug-resistant serotype-19A, among children <5 years in Bogotá-Colombia.

Hide

A NEW FLEXIBLE-GENOMIC TWO-COMPONENT REGULATORY SYSTEM FOR STREPTOCOCCUS PNEUMONIAE AND THE IMPACT OF PNEUMOCOCCAL VACCINES FROM ANOTHER GENOMIC PERSPECTIVE (ID 399)